Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale

In 2024, medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale trade exhibited strong growth, with global flows reaching $4,452,891,680 and a three-year compound annual growth rate of +74.0% (five-year: +46.3%). The all-time peak of $4,452,891,680 was recorded in 2024.

Over the 30-year observation window (1995–2024), 62% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is strengthening (+61.7% acceleration).

The World Trade Flows Characterization classifies medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale as "One-way trade" in the medium price range price segment, providing additional context for market positioning and competitive dynamics.

The supply side is concentrated (Herfindahl-Hirschman Index 0.602). The three largest exporters — Ireland ($3.4B), United States ($356.9M), and Denmark ($184.7M) — collectively dominate supply flows. The leading exporter has grown at +671.3% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.596). The three largest import markets are Belgium ($3.4B), Denmark ($259.0M), and Germany ($108.0M). The largest importing market sources from 12 different supplying countries.

Estimated substitution elasticity: -22.15. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is Ireland → Belgium at $3.4B, representing 99.9% of the importer's total demand.

The volatility score for medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale is 35 out of 100, classified as low. Trade flows are moderately variable, typical for goods with seasonal or cyclical demand patterns.

For market entrants, strong demand tailwinds create a favourable entry environment. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.